Yestar Healthcare Holdings Company Limited (2393.HK)
- Previous Close
0.079 - Open
0.080 - Bid 0.077 x --
- Ask 0.080 x --
- Day's Range
0.080 - 0.080 - 52 Week Range
0.035 - 0.225 - Volume
25,000 - Avg. Volume
3,265,431 - Market Cap (intraday)
186.527M - Beta (5Y Monthly) -0.07
- PE Ratio (TTM)
0.19 - EPS (TTM)
0.430 - Earnings Date Mar 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 5, 2018
- 1y Target Est
--
Yestar Healthcare Holdings Company Limited, an investment holding company, manufactures and sells medical imaging products in Mainland China. The company operates through two segments: Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells Fujifilm color photographic paper, industrial NDT X-ray films, and PWB films; and trades in imaging equipment. The company products are used in professional and minilabs; and industrial imaging applications. This segment provides NDT X-ray films under the Yes!Star brand name. Its Medical Products and Equipment segment manufactures and sells medical dry and wet films, and dental films; and sells and distributes medical equipment and diagnostic reagents. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. The company was founded in 1971 and is headquartered in Shanghai, the People's Republic of China.
www.yestarcorp.comRecent News: 2393.HK
View MorePerformance Overview: 2393.HK
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2393.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2393.HK
View MoreValuation Measures
Market Cap
186.53M
Enterprise Value
403.89M
Trailing P/E
0.19
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.07
Price/Book (mrq)
0.37
Enterprise Value/Revenue
0.15
Enterprise Value/EBITDA
0.36
Financial Highlights
Profitability and Income Statement
Profit Margin
38.24%
Return on Assets (ttm)
-3.09%
Return on Equity (ttm)
1,644.78%
Revenue (ttm)
2.41B
Net Income Avi to Common (ttm)
921.08M
Diluted EPS (ttm)
0.430
Balance Sheet and Cash Flow
Total Cash (mrq)
151.78M
Total Debt/Equity (mrq)
62.35%
Levered Free Cash Flow (ttm)
15.56M